Johnson & Johnson Single-Shot COVID-19 Vaccine Candidate Unanimously Recommended for Emergency Use Authorization by U.S. FDA Advisory Committee | Johnson & Johnson
Vote based on totality of scientific evidence provided by the Company including safety and efficacy data